Navigation Links
Fish Oil Might Help Relieve MS
Date:8/24/2007

Omega-3 fatty acids ease immune dysfunction, study suggests

FRIDAY, Aug. 24 (HealthDay News) -- Fish oil containing omega-3 fatty acids could benefit multiple sclerosis (MS) patients, a U.S. study finds.

Omega-3 fatty acids contain eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which affect blood proteins called matrix metalloproteinase-9 (MMP-9) produced by the immune cells of MS patients.

The new study was conducted by researchers at the Oregon Health & Science University and the VA Medical Center in Portland. They had 10 MS patients receive 9.6 grams of fish oil per day.

After three months of taking the fish oil, the researchers noted a 58 percent decrease in MMP-9 levels secreted from the MS patients' immune cells. There was also a significant increase in EPA and DHA levels in the patient's red blood cell membranes.

"The findings confirm previous research findings that suggest the intake of fish oil containing omega-3 fatty acids could provide a measure of relief for those with MS, a disease that is progressive, debilitating, and without a cure," lead researcher L. Shinto said in a prepared statement.

The study was presented this week at the American Association of Naturopathic Physicians annual meeting, in Palm Springs, Calif.

More information

The American Medical Association has more about MS.



-- Robert Preidt



SOURCE: American Association of Naturopathic Physicians, news release, Aug. 22, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. OBESE LIL GIRLS !! SWEAT IT OUT OR U MIGHT BE ASTHAMATIC !!!
2. Biochemical Markers Might Help Predict Heart Problems
3. Yoga Might Be Helpful For Cancer Patients
4. Suicide might be inherited
5. Cleanliness might lead to Asthma
6. Stroke risk might be linked to antibody
7. Change in walking might indicate Dementia
8. Drug might prevent Prostate Cancer Spread
9. Anemia Treatment for Cancer Patients Might Not be a Good Idea.
10. Diet might just have an Effect on Breast Cancer
11. Tomatoes Might Inhibit the Development Of Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon Kleyne ... signature product of her research center at Bio-Logic Aqua Research® Water Life Science®, ... the greatest number of sufferers of blindness. “We think that Nature’s Tears® EyeMist® ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... may give insight into why concussion rates are on the rise, say researchers ... Annual Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... enterprise-grade IT operations analytics and application performance monitoring (APM) solutions, has expanded ... healthcare services providers. , According to Peter Ohrenberger, sales director at Nastel, ...
(Date:7/20/2017)... ... July 20, 2017 , ... Team Type 1 Foundation, a ... for everyone affected by diabetes, is teaming up with a Microsoft Corp. employee-led hackathon ... off on July 24th. , “Team Type 1’s mission overlaps seamlessly with Microsoft’s ...
(Date:7/20/2017)... ... July 20, 2017 , ... Using CDRH’s Medical Device ... — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/mdqualitydata          , Device makers ... It’s known as the “CY2016 Annual FDA Medical Device Quality System Data” report. ...
Breaking Medicine News(10 mins):
(Date:7/6/2017)... division of Diplomat Specialty Infusion Group, is celebrating a decade of empowering ... celebrate its anniversary, ThriveRx recently launched a redesigned website at thriverx.diplomat.is ... to create the best user experience for consumers and health care professionals. ... Diplomat Pharmacy ... "We,ve made several great strides throughout the past 10 years," ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... a clinical-stage pharmaceutical company focused on the development of oral ... from the Israel Securities Authority to dual-list its common stock ... will commence trading on the TASE on July 12, 2017 ... of the Company, it is expected that Oramed will be ...
(Date:7/5/2017)... Wash. , July 5, 2017   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... cryopreservation freeze media ("BioLife"), today announced that it ... its debt holder and largest shareholder, to modify its ... Pursuant to the modification, WAVI agreed to exchange ...
Breaking Medicine Technology: